VALN Stock Analysis: Buy, Sell, or Hold?

VALN - Valneva SE American Depositary Shares

Biological Products, (No Diagnostic Substances)
$9.21
-0.20 (-2.13%) ▼
HOLD
LOW Confidence
Protect Your VALN Gains
Last Updated: January 30, 2026
Earnings: Mar 19, 2026

Get Alerted When VALN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: VALN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: VALN is currently trading at $9.21, which is considered fair relative to its 30-day fair value range of $8.77 to $10.02.

Technical Outlook: Technically, VALN is in a downtrend. The price is currently testing key support at $9.11. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.89 (+37.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Fair Price Range $8.77 - $10.02
Company Quality Score 51/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.7%

Protect Your Profits

Holding VALN? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 37.0% below Wall St target ($12.89)
  • CAUTION: Recommendation downgraded due to -5.7% 5-day decline

Fair Price Analysis

30-Day Fair Range $8.77 - $10.02
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $9.11
Resistance Level $10.32
Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) -8.63
Wall Street Target $12.89 (+37.0%)
Revenue Growth (YoY) -35.8%
Profit Margin -56.8%
Last updated: January 30, 2026 5:36 PM ET
Data refreshes hourly during market hours. Next update: 6:36 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$21 54 HOLD
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
33 analysts
$486 45 HOLD
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$500 62 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$91 64 BUY
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$830 52 HOLD

Advanced VALN Option Strategies

Professional options setups generated by AI based on today's VALN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for VALN

VALN Technical Chart VALN Price Prediction VALN Earnings Date VALN Investment Advisor VALN Fair Price Analyzer VALN Options Advisor VALN Options Chain VALN Options Analysis VALN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals